Innocoll AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Innocoll AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10813
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Innocoll AG (Innocoll), formerly Innocoll Holdings Plc is a pharmaceutical company that carries out the development and manufacturing of surgical implants and topically applied healthcare products in the areas of unmet clinical needs. The company’s pipeline product Xaracoll, a bupivacaine HCl collagen-matrix implant and collagen-based delivery technology has been studied in two Phase III clinical trials for postsurgical analgesia as part of multi-modal therapy for patients undergoing hernia repair. Its Xaracoll has been studied to deliver the anesthetic directly at the surgical site and to reduce pain and opioid use after surgery. The company partners with other pharma companies to market its various products. It operates across the US, Ireland, and Germany. Innocoll is headquartered in Athlone, Ireland.

Innocoll AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Innocoll AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Innocoll AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Innocoll AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Innocoll AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Innocoll AG, Medical Devices Deals, 2012 to YTD 2018 9
Innocoll AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Innocoll AG, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Gurnet Point Acquires Innocoll for USD209 Million 11
Licensing Agreements 13
Innocoll Enters Into Licensing Agreement With Flynn Pharma For CollaGUARD 13
Equity Offering 14
Innocoll Raises USD40 Million in Public Offering of Shares 14
Innocoll Raises USD29.89 million in Public Offering of American Depository Shares 16
Innocoll Raises USD58.5 Million in IPO 17
Innocoll AG – Key Competitors 19
Innocoll AG – Key Employees 20
Innocoll AG – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Mar 16, 2017: Innocoll Holdings Announces Fourth Quarter and Full-Year 2016 Financial and Operating Results and Provides Corporate Update 22
Product Approvals 24
Mar 29, 2017: Innocoll announces regulatory path forward after receiving formal FDA Type A meeting minutes regarding its XARACOLL (bupivacaine HCl collagen-matrix implant) New Drug Application 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Innocoll AG, Pharmaceuticals & Healthcare, Key Facts 2
Innocoll AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Innocoll AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Innocoll AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Innocoll AG, Deals By Therapy Area, 2012 to YTD 2018 8
Innocoll AG, Medical Devices Deals, 2012 to YTD 2018 9
Innocoll AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Gurnet Point Acquires Innocoll for USD209 Million 11
Innocoll Enters Into Licensing Agreement With Flynn Pharma For CollaGUARD 13
Innocoll Raises USD40 Million in Public Offering of Shares 14
Innocoll Raises USD29.89 million in Public Offering of American Depository Shares 16
Innocoll Raises USD58.5 Million in IPO 17
Innocoll AG, Key Competitors 19
Innocoll AG, Key Employees 20
Innocoll AG, Subsidiaries 21

List of Figures
Innocoll AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Innocoll AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Innocoll AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Innocoll AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Innocoll AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Innocoll AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Innocoll AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Innocoll AG, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Innocoll AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Microchip Technology Incorporated:企業のM&A・事業提携・投資動向
    Microchip Technology Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Microchip Technology Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Technology Nexus AB:企業の戦略的SWOT分析
    Technology Nexus AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Rutherford Electric Membership Corp:企業の戦略的SWOT分析
    Rutherford Electric Membership Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Yamana Gold Inc.:企業のM&A・事業提携・投資動向
    Yamana Gold Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Yamana Gold Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • ProteinSimple-製薬・医療分野:企業M&A・提携分析
    Summary ProteinSimple, formerly Cell Biosciences Inc, a subsidiary of Bio Techne Corp, is a medical device company that offers protein analysis solutions. The company offers products such as simple plex systems, simple western systems, micro-flow imaging systems, cIEF and CE-SDS; gel documentation s …
  • Keysight Technologies Inc:戦略・SWOT・企業財務分析
    Keysight Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary Keysight Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • British Airways Plc:企業の戦略的SWOT分析
    British Airways Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Novo Nordisk AS (NOVO B):企業の財務・戦略的SWOT分析
    Novo Nordisk AS (NOVO B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cytokinetics Inc (CYTK):製薬・医療:M&Aディール及び事業提携情報
    Summary Cytokinetics Inc (Cytokinetics) is a late stage biopharmaceutical company, which discovers, develops, and commercializes muscle activators for the treatment of diseases associated with reduced muscle performance. The company’s pipeline encompasses omecamtiv mecarbil, a novel cardiac myosin a …
  • Korea East-West Power Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Korea East-West Power Co., Ltd. (EWP), subsidiary of Korea Electric Power Corporation, is a state-owned electric utility that generates and supplies electricity. It produces electricity from various sources including coal, oil, liquefied natural gas, mini hydro, and renewable sources such as …
  • Paymark:企業の戦略的SWOT分析
    Paymark - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Bureau Veritas SA (BVI):企業の財務・戦略的SWOT分析
    Bureau Veritas SA (BVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • ULURU Inc (ULUR):医療機器:M&Aディール及び事業提携情報
    Summary ULURU Inc (ULURU) is a medical technology company that researches, develops, and markets wound care and muco-adhesive film products. The company’s products include Altrazeal and OraDisc. Its Altrazeal is a transforming powder dressing with Nanoflex technology for the management of exuding wo …
  • Total SA (FP)-石油・ガス分野:企業M&A・提携分析
    Summary Total S.A. (Total) is an integrated global oil and gas company that produces, refines and markets oil, and also manufactures petrochemicals. It carries out drilling, oil and gas production, processing, transportation, refining and petrochemical production, storage and distribution of petrole …
  • Curemark LLC-医療機器分野:企業M&A・提携分析
    Summary Curemark LLC (Curemark) is a biopharmaceutical company that offers development of novel therapies. The company develops novel therapies to treat serious diseases for which there are limited treatment options. It provides CM-AT, CM-4612, CM-PK, CM-182, and CM-1212 drugs. Curemark’s product ca …
  • Michigan Public Power Agency:企業の戦略的SWOT分析
    Michigan Public Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • NovImmune SA:製薬・医療:M&Aディール及び事業提携情報
    Summary NovImmune SA (NovImmune) is a biopharmaceutical company that discovers and develops antibody-based drugs for the treatment of inflammatory diseases, immune-related disorders and cancer. The company develops pipeline products using its proprietary mAb generating platform, DiversityTrap and ka …
  • PHX Energy Services Corp (PHX):企業の財務・戦略的SWOT分析
    Summary PHX Energy Services Corp (PHX Energy), formerly Phoenix Technology Income Fund is an energy service company that manufactures, designs, and engineers directional drilling technologies. The corporation’s equipment includes RADD, P-360 MWD, E-360 MWD, 360 RWD, and performance motors and others …
  • St. James’S Place Plc
    St. James'S Place Plc - Strategy, SWOT and Corporate Finance Report Summary St. James'S Place Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Centene Corporation:企業の戦略・SWOT・財務情報
    Centene Corporation - Strategy, SWOT and Corporate Finance Report Summary Centene Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆